ÂÜÀòÂÒÂ×

Xiaojun Guo is a seasoned professional in drug safety and pharmacovigilance with extensive experience in the pharmaceutical industry. Currently serving as Senior Director and Head of Drug Safety and Pharmacovigilance at Hutchison MediPharma since January 2017, Xiaojun previously held the position of Head of Clinical Safety and Pharmacovigilance at GlaxoSmithKline from March 2012 to January 2017. Earlier roles included Associate Director of Patient Safety, Patient Safety Manager, and Research Alliance Leader at AstraZeneca, as well as Project Manager positions at Quintiles and Loudon Far East. Xiaojun began a career in medicine as a physician at the 2nd Hospital of Harbin Medical University from 1995 to 1997. Educational achievements include a Master's degree in Clinical Medicine and a Doctorate in Internal Medicine-CV from Harbin Medical University.